Dr Dana D Dameron Jr, DO | |
475 Nw Prima Vista Blvd, Port St Lucie, FL 34983-8731 | |
(772) 800-3037 | |
(772) 807-1409 |
Full Name | Dr Dana D Dameron Jr |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 15 Years |
Location | 475 Nw Prima Vista Blvd, Port St Lucie, Florida |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013242932 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | OS11959 (Florida) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Cleveland Clinic Martin North Hospital | Stuart, FL | Hospital |
Entity Name | Healthy Results Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1578965653 PECOS PAC ID: 7113247636 Enrollment ID: O20150526000767 |
News Archive
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for the subcutaneous formulation of ORENCIA® (abatacept), a treatment for adult patients with moderate to severe rheumatoid arthritis (RA) administered through an injection into the skin. Bristol-Myers Squibb submitted the sBLA to the FDA for the subcutaneous formulation of ORENCIA and received confirmation of its receipt on October 4, 2010.
Research scientists at Karolinska Institutet are planning an international initiative to map out the relationships between health, genes and lifestyle. Discussion partners include world-leading researchers from the USA, Britain, Singapore and Norway.
A discovery, several years in the making, by a University at Buffalo research team has proven that adult skin cells can be converted into neural crest cells (a type of stem cell) without any genetic modification, and that these stem cells can yield other cells that are present in the spinal cord and the brain.
Health advocates cheered last month's U.S. Food and Drug Administration (FDA) proposal to ban partially hydrogenated oils - which contain trans fats that increase the risk of heart disease - but some wonder whether the substitutes for these fats will be any healthier.
ConnexOntario's appointment booking facilitates the quick and efficient scheduling of appointments with MOHLTC-funded problem gambling counselling services. Along with live-answer information and referral, system education, and short-term support, individuals contacting ConnexOntario's service, the Ontario Problem Gambling Helpline, receive immediate assistance and encouragement to take further steps to access treatment services and, to facilitate this, can now be offered an appointment date and time with registered organizations.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Dana D Dameron Jr, DO 475 Nw Prima Vista Blvd, Port St Lucie, FL 34983-8731 Ph: (772) 800-3037 | Dr Dana D Dameron Jr, DO 475 Nw Prima Vista Blvd, Port St Lucie, FL 34983-8731 Ph: (772) 800-3037 |
News Archive
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for the subcutaneous formulation of ORENCIA® (abatacept), a treatment for adult patients with moderate to severe rheumatoid arthritis (RA) administered through an injection into the skin. Bristol-Myers Squibb submitted the sBLA to the FDA for the subcutaneous formulation of ORENCIA and received confirmation of its receipt on October 4, 2010.
Research scientists at Karolinska Institutet are planning an international initiative to map out the relationships between health, genes and lifestyle. Discussion partners include world-leading researchers from the USA, Britain, Singapore and Norway.
A discovery, several years in the making, by a University at Buffalo research team has proven that adult skin cells can be converted into neural crest cells (a type of stem cell) without any genetic modification, and that these stem cells can yield other cells that are present in the spinal cord and the brain.
Health advocates cheered last month's U.S. Food and Drug Administration (FDA) proposal to ban partially hydrogenated oils - which contain trans fats that increase the risk of heart disease - but some wonder whether the substitutes for these fats will be any healthier.
ConnexOntario's appointment booking facilitates the quick and efficient scheduling of appointments with MOHLTC-funded problem gambling counselling services. Along with live-answer information and referral, system education, and short-term support, individuals contacting ConnexOntario's service, the Ontario Problem Gambling Helpline, receive immediate assistance and encouragement to take further steps to access treatment services and, to facilitate this, can now be offered an appointment date and time with registered organizations.
› Verified 6 days ago
Dr. Theodore G Pettle, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1700 Se Hillmoor Dr, Port St Lucie, FL 34952 Phone: 772-335-9600 | |
Alan Steven Collin, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1871 Se Tiffany Ave, Suite 100, Port St Lucie, FL 34952 Phone: 772-335-5666 Fax: 772-335-4826 | |
Dr. Gerald John Rutecki, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 473 Nw Blue Lake Dr, Port St Lucie, FL 34986 Phone: 772-336-8039 | |
Ahmet Bahadir Ergin, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1700 Se Hillmoor Dr, Port St Lucie, FL 34952 Phone: 772-335-9600 Fax: 772-335-7972 | |
Dr. Philip Lortz, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1855 Se Port St Lucie Blvd, Port St Lucie, FL 34952 Phone: 772-288-6300 Fax: 772-288-6374 | |
Edwin Benedict Flanagan, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1651 Se Tiffany Ave, Port St Lucie, FL 34952 Phone: 772-398-1800 Fax: 772-398-1815 |